Ligand Pharmaceuticals Incorporated Gains 28.89%
Wed, Nov 02, 2022 at 07:29 PM
Ligand Pharmaceuticals Incorporated (LGND:NASDAQ) shot up at $68, representing a gain of 28.9%. On Wed, Nov 02, 2022, LGND:NASDAQ hit a New 2-Week Low of $68. The stock appeared on our News Catalysts scanner on Tue, Nov 01, 2022 at 12:15 PM in the 'EARNINGS' category. From Wed, Oct 19, 2022, the stock recorded 30.00% Up Days and 27.27% Green Days
About Ligand Pharmaceuticals Incorporated (LGND:NASDAQ)
Ligand Pharmaceuticals Inc is a biopharmaceutical company. Its business model is based upon the concept of acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure.
Top 10 Gainers:
- Starry Group Holdings Inc. Class A (STRY:NYSE), 55.56%
- Creatd Inc. (CRTD:NASDAQ), 53.94%
- Benefitfocus, Inc. (BNFT:NASDAQ), 48.21%
- Forza X1 Inc. (FRZA:NASDAQ), 44.97%
- Bull Horn Holdings Corp. (BHSE:NASDAQ), 44.67%
- Bandwidth Inc. (BAND:NASDAQ), 41.63%
- Rayonier Advanced Materials Inc. (RYAM:NYSE), 34.23%
- Ligand Pharmaceuticals Incorporated (LGND:NASDAQ), 28.89%
- Chegg, Inc. (CHGG:NYSE), 21.98%
- Huadi International Group Co. Ltd. (HUDI:NASDAQ), 21.27%